Global Precision Medicine Market Revenue and Share Analysis Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the precision medicine market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Precision Medicine Market In The Period 2029-2034?

The precision medicine market has shown robust expansion in recent years. It is anticipated to increase from $80.15 billion in 2024 to $87.91 billion in 2025, at a compound annual growth rate (CAGR) of 9.7%. This historical growth can be linked to a rise in cancer prevalence, the growing incidence of mental health disorders, an increased occurrence of respiratory diseases, greater funding, an expanding geriatric population, a surge in pharmaceutical R&D expenditure, and elevated healthcare expenditure.

The precision medicine market is anticipated to experience substantial expansion in the coming years. Projections indicate it will reach a value of $126.14 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.4%. This growth during the forecast period is primarily driven by factors such as the rising elderly population, the growing incidence of cancer, the significant opportunities in developing economies, the emergence of new pathogenic diseases, increased expenditure on research and development, and a general increase in healthcare spending. Key developments expected within this period involve the integration of artificial intelligence technologies to enhance competitive advantage, the provision of diagnostic tools and tailored treatments for immune-mediated conditions, heightened investment in research and development initiatives, and the establishment of partnerships and alliances with technological and healthcare organizations to broaden product offerings.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5301&type=smp

What Strategic Drivers Are Accelerating The Precision Medicine Market Expansion?

The increasing occurrence of cancer is anticipated to stimulate the expansion of the precision medicine market. Globally, cancer represents a primary contributor to mortality, with one out of every five individuals developing it at some stage in their lives. In cancer care, precision medicine involves analyzing DNA from tumors to identify mutations or other genetic abnormalities responsible for the disease. This process allows physicians to select treatments for specific patients that precisely match, or target, these alterations in tumor DNA. For instance, in February 2024, the World Health Organization, a Switzerland-based specialized agency focused on international public health, projected that new cancer cases will surpass 35 million by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer is a significant driver for the growth of the precision medicine market.

What Is The Detailed Segment Distribution Of The Precision Medicine Market?

The precision medicine market covered in this report is segmented –

1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology

2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.

3) By End-Use: Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others

Subsegments:

1) By Big Data Analytics: Predictive Analytics, Prescriptive Analytics, Data Mining

2) By Bioinformatics: Genomic Data Analysis, Proteomics Data Analysis, Metabolomics Data Analysis

3) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Whole Genome Sequencing

4) By Drug Discovery: Target Identification And Validation, Lead Compound Discovery, Preclinical And Clinical Trials

5) By Companion Diagnostics: Biomarker Testing, Genomic Profiling, Companion Diagnostic Tests

6) By Other Technology: Personalized Treatment Plans, Telemedicine And Digital Health Solutions, Wearable Health Technology

How Are Global Trends Impacting The Development Of The Precision Medicine Market?

An increasing volume of collaborations and company takeovers within the precision medicine sector allows these firms to broaden their methodologies across both cancer and non-cancer fields. Given that precision medicine is constantly evolving through research and development into novel domains, alliances and joint ventures are instrumental in strengthening the capabilities and strategies of these companies. A prime example is GSK plc, a pharmaceutical firm from the UK, which in September 2022, extended its partnership with Tempus, a precision medicine company based in the US. This three-year collaborative agreement seeks to refine the design of clinical trials, accelerate patient recruitment, and pinpoint potential drug targets, leveraging Tempus’ advanced AI-enabled platform and vast collection of de-identified patient information. This joint effort extends their prior undertakings and is anticipated to bolster GSK’s research and development capacities, especially within the field of oncology.

Who Are The Major Stakeholders Operating In The Precision Medicine Market?

Major companies operating in the precision medicine market include Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, União Quimica

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Precision Medicine Market?

North America was the largest region in the precision medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=5301&type=smp

Browse Through More Reports Similar to the Global Precision Medicine Market 2025, By The Business Research Company

Electronic And Precision Equipment Repair And Maintenance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/electronic-and-precision-equipment-repair-and-maintenance-global-market-report

Research Antibodie And Reagent Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

Catalyst Fertilizer Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/catalyst-fertilizer-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795